Clinical trials and pregnancy: regulators weigh in
Clarivate
MARCH 17, 2022
Drug developers often face a Catch-22 regarding clinical trials and pregnancy. How feasible is it to establish a drug’s safety for use in a population that may be unwilling or unable to participate in clinical trials? We look at the outcome of a recent Food and Drug Administration meeting and their draft guidance for more information.
10 
Let's personalize your content